Phil Ferneau

Phil Ferneau is a prominent figure in the venture capital industry, particularly in the healthcare sector. He is the Co-Founder and Managing Partner of Borealis Ventures, an early-stage healthcare venture capital firm based in Hanover, New Hampshire.1 Borealis Ventures focuses on life science platforms, digital health, and animal health opportunities.1

Professional Experience

Ferneau has extensive experience in investing and serving on the boards of numerous healthcare and biotechnology companies. Some of his notable board positions include:

• Compass Therapeutics LLC (Nasdaq: CMPX)
• Ankyra Therapeutics
• Amagma Therapeutics
• Ovation.io
• T-Cypher Bio
• Orbit Discovery1

He has also been an investor in successful companies such as Adimab, Evox Therapeutics, and previously, GlycoFi, which was acquired by Merck & Co. for $400 million.1

Academic Involvement

In addition to his venture capital work, Ferneau serves as an Adjunct Professor at the Tuck School of Business at Dartmouth College.1 He teaches venture capital topics and contributes to advancing Dartmouth's entrepreneurial ecosystem. Previously, he was the founding executive director of Tuck's Center for Venture Capital and Private Equity.1

Education

Ferneau holds multiple degrees:

• J.D. from the University of Virginia School of Law
• A.B. from Dartmouth College
• MBA from the Tuck School of Business at Dartmouth1

Social Media Presence

Phil Ferneau maintains an active presence on professional social media platforms. On Twitter, he describes himself as an "Early-stage healthcare VC investor (Borealis Ventures) and adjunct professor of VC at Dartmouth's Tuck School of Business".2 His LinkedIn profile, under the username pferneau, provides a comprehensive overview of his professional experience and achievements.1